Please login to the form below

Not currently logged in
Email:
Password:

genetic diseases

This page shows the latest genetic diseases news and features for those working in and with pharma, biotech and healthcare.

UK government allocates up to £680m a year to two funds offering cutting-edge treatments

UK government allocates up to £680m a year to two funds offering cutting-edge treatments

The IMF will provide potentially life-saving drugs for rare and genetic diseases, with the UK government pledging up to £680m per year to be divided up between the funds.

Latest news

More from news
Approximately 0 fully matching, plus 76 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • Improving healthcare for rare disease patients Improving healthcare for rare disease patients

    With the majority of rare diseases having a genetic component, the more widespread use of whole genome sequencing in recent years has helped with the detection of rare genetic abnormalities and ... Resource.Accessed March 1, 2022. Genetic and Rare

  • Rare Disease Day – looking to the future with hope Rare Disease Day – looking to the future with hope

    by a genetic deficiency in an enzyme involved in tyrosine metabolism, which results in a build-up of homogentisic acid, manifesting in ‘black urine’ ( Orphanet Journal of Rare Diseases). ... diseases. The study demonstrated an increase in diagnostic

  • Rare Disease Day in a COVID-19 environment

    1). With 8 out of 10 rare diseases considered to have a genetic component. ... Clinical Geneticists and Genetic Counsellors are part of the multi-disciplinary team and network of dedicated professionals who ensure continuity of care and treatment for

  • OPEN Health’s virtual reflections on the World Orphan Drug Congress US OPEN Health’s virtual reflections on the World Orphan Drug Congress US

    We learned throughout the week that more than an estimated 40% of future drug approvals will concentrate on rare diseases and genetic disorders. ... Improving the diagnosis of rare diseases is a typical challenge and it was interesting to hear the

  • AMICULUM® launches new specialist agency: AMICULUM Access

    Never has this been more apparent than with the increasing number of exciting products developed for rare and genetic diseases. ... AMICULUM already delivers high-quality market access projects through our medical communications teams – especially in

More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....